Investment analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a note issued to investors on Wednesday. The firm set a “buy” rating on the stock.
Mannatech Stock Down 2.0 %
Mannatech stock opened at $8.17 on Wednesday. The stock has a market cap of $15.36 million, a PE ratio of -6.95 and a beta of 1.20. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.51 and a current ratio of 1.07. Mannatech has a one year low of $7.50 and a one year high of $15.10. The stock has a fifty day moving average of $8.60 and a 200 day moving average of $8.77.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings data on Thursday, March 28th. The company reported ($0.94) EPS for the quarter. The firm had revenue of $32.69 million for the quarter. Mannatech had a negative net margin of 1.70% and a negative return on equity of 19.19%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- What are earnings reports?
- Hasbro’s Management Made All the Right Calls This Quarter
- Trading Stocks: RSI and Why it’s Useful
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What is an Earnings Surprise?
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
